Article Text

Download PDFPDF
Albendazole therapy in patients with solitary cerebral cysticercus granuloma. Is it effective?
  1. Vedantam Rajshekhar
  1. Professor V Rajshekhar, Department of Neurological Sciences, Christian Medical College and Hospital Vellore, 632 004 Tamil, Nadu, India; rajshekhar{at}cmcvellore.ac.in

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

This is the question that Thussu and colleagues1 set out to answer in their study published in this issue of J Neurol Neurosurg Psychiatry (see page 272). Solitary cysticercus granuloma (SCG) is the commonest form of neurocysticercosis seen in India and is also diagnosed in several patients all over the world. Although the granuloma resolves spontaneously, the rate of resolution is variable and could take anywhere from a few weeks to several years.2 Any cysticidal therapy (albendazole) that could reliably and safely hasten the resolution of the granuloma will have several benefits. Firstly, the diagnosis of SCG would …

View Full Text

Footnotes

  • Competing interests: None.

Linked Articles